Plasmin accelerates platelet-dependent prothrombinase formation without activating the platelets

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 458-465

  Liu, Longbin ^a,b   Freedman, John ^c   Hornstein, Adriana ^c   Dewar, Lori ^a   Blajchman, Morris A ^a,b   Ofosu, Frederick A ^a,b  

^a Canadian Red Cross Society   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Plasmin; Platelets; Thrombin; Thrombolytic therapy

Indexed keywords

BLOOD CLOTTING FACTOR 10A; PLASMIN; PROTHROMBIN;

ARTICLE; BLOOD CLOT LYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOSIS;

EID: 0030023994     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1467.x     Document Type: Article

References (40)

1. Abrams, C.S., Ellison, N., Budzynski, A.Z. & Shattil, S.J. (1990) Direct detection of activated platelets and platelet-derived microparticles in humans. Blood, 75, 128-138.
2. Aronson, D.L., Chang, P. & Kessler, C.M. (1992) Platelet-dependent thrombin generation after in vitro fibrinolytic treatment. Circulation, 85, 1706-1712.
3. Baruch, D., Hemker, H.C. & Lindhout T. (1986) Kinetics of thrombin-induced release and activation of platelet factor V. European Journal of Biochemistry, 154, 213-218.
4. Collen, D. & Lijnen, H.R. (1991) Basic and clinical aspects of fibrinolysis and thrombolysis. Blood, 78, 3114-3124.
5. Coller, B.S. (1990) Platelets and thrombolytic therapy. New England Journal of Medicine, 322, 33-42.
6. Eisenberg, P.R., Sherman, L.A. & Jaffe, A.S. (1992) Activation of prothrombin accompanying thrombolysis with rt-PA. Journal of the American College of Cardiology, 19, 1065-1069.
7. Eisenberg, P.R., Sherman, L.A., Rich, M., Schwartz, D., Schectman, K., Geltman, E.M., Sobel, B.E. & Jaffe, A.S. (1986) Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis. Journal of the American College of Cardiology, 7, 1255-1262.
8. Ewald, G.A. & Eisenberg, P.R. (1994) Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. Circulation, 91, 28-36.
9. Fitzgerald, D.J., Catella, F., Roy, L. & Fitzgerald, G.A. (1988) Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation, 77, 142-150.
10. Fitzgerald, D.J. & Fitzgerald, G.A. (1989) Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proceedings of the National Academy of Sciences of the united States of America, 86, 7585-7589.
11. 2 modulate the response to tissue-type plasminogen activator in vivo. Circulation Research, 65, 83-94.
12. George, J.N., Nurden, A.T. & Phillips, D.R. (eds) (1985) Platelet Membrane Glycoproteins. Plenum Press, New York.
13. Gold, H.K., Coller, B.S., Yasuda, T., Saito, T., Fallon, J.T., Guerrero, J.L., Leinbach, R.C., Ziskind, A.A. & Collen, U. (1988) Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. Circulation, 77, 670-677.
14. Gold, H.K., Leinbach, R.C., Garabedian, H.D., Yasuda, T., Johns, J.A., Grossbard, E.B., Palacios, I. & Collen, D. (1986) Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation, 73, 347-352.
15. Gouin, I., Lecompte, T., Morel, M.C., Lebrazi, J., Modderman, P.W., Kaplan, C. & Samama, M.M. (1992) In vitro effect of plasmin on human platelet function in plasma: inhibition of aggregation caused by fibrinolysis. Circulation, 85, 935-941.
16. Gulba, D.C., Westhoff-Bleck, M., Jost, S., Rafflenbeul, W., Daniel, W.G., Hecker, H. & Lichtlen, P.R. (1991) Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Circulation, 83, 937-944.
17. Heras, M., Thompson, P.L. Chesebro, J.H. & Fuster, V. (1989) Prevention of early and late rethrombosis and further strategies after coronary reperfusion. Thrombolysis in Cardiovascular Disease (ed. by D. Julian, W. Kubler, R. M. Norris, et al), pp. 3203-3229. Decker, Basel.
18. Hynes, R.O. (1987) Integrins: a family of cell surface receptors. Cell. 48, 549-554.
19. Laudano, A.P. & Doolittle, R.F. (1980) Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization: structural requirements, number of binding sites and species differences. Biochemistry, 19, 1013-1019.
20. Liu, L., Freedman, J., Dewar, L. & Ofosu, F.A. (1994a) Platelets are the primary source of factor Va for prothrombinase formation in platelet-rich plasma. Blood, 84, 191a.
21. Liu, L., Freedman, J., Hornstein, A., Fenton, J., II & Ofosu, F.A. (1994b) Thrombin binding to platelets and their activation in plasma. British Journal of Haematology, 88, 592-600.
22. Loscalzo, J. & Braunwald, E. (1988) Tissue plasminogen activator. New England Journal of Medicine, 319, 925-931.
23. Mann, K.G., Krishnaswamy, S. & Lawson, J.H. (1992) Surface-dependent hemostasis. Seminars in Hematology, 29, 213-226.
24. McEver, R.P. & Martin, M.N. (1984) A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. Journal of Biological Chemistry, 259, 9799-9804.
25. Meijer, A., Verheugt, F.W.A., Werter, C.J.P.J., Lie, K.I., van der Pol, J.M.J. & van Eenige, M.J. (1993) Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT study. Circulation, 87, 1524-1530.
26. Mustard, J.F., Perry, D.W., Ardlie, N.G. & Packham, M.A. (1972) Preparations of suspensions of washed platelets from humans. British Journal of Haematology, 22, 193.
27. Ofosu, F.A., Blajchman, M.A. & Hirsh, J. (1980) The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin III. Thrombosis Research, 20, 391-403.
28. Owen, J., Friedman, K.D., Grossman, B.A., Wilkins, C., Berke, A.D. & Powers, E.R. (1988) Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood, 72, 616-620.
29. Pelzer, H., Schwarz, A. & Stuber, W. (1991) Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thrombosis and Haemostasis, 65, 153-159.
30. Rigel, D.F., Olson, R.W. & Lappe, R.W. (1993) Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis. Circulation Research, 72, 1091-1102.
31. Rudd, M.A., George, D., Johnstone, M.T., Moore, R.T., Collins, L., Rabbani, L.E. & Loscalzo, J. (1992) Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy. Circulation Research, 70, 829-834.
32. Seitz, R., Pelzer, H. & Egbring, I.R. (1993) Prothrombin activation by thrombolytic agents. Fibrinolysis, 7, 109-115.
33. Shattil, S.J., Gunningham, M. & Hoxie, J.A. (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 70, 307-315.
34. Tracy, P.B. (1988) Regulation of thrombin generation. Seminars in Thrombosis and Hemostasis, 14, 227-233.
35. Tracy, P.B., Eide, L.L., Bowie, E.J.W. & Mann, K.G. (1982) Radioimmunoassay of factor V in human plasma and platelets. Blood, 60, 59-63.
36. Turner, J.S., Redpath, G.T., Humphries, J.E., Gonias, S.L. & Vandenberg, S.R. (1994) Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. Biochemical Journal, 297, 175-179.
37. Waxman, L., Smith, D.E., Arcuri, K.E. & Vlasuk, G.P. (1990) Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science, 248, 593-596.
38. 2+. Blood, 76, 1546-1557.
39. Winters, K.J., Santoro, S.A., Miletich, J.P. & Eisenberg, P.R. (1991) Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase. Circulation, 84, 1552-1560.
40. Wyschock, E.G., Stewart, G.J. & Colman, R.W. (1994) Thrombin-stimulated human platelets express molecular forms of α-granule factor V (FV) which differ from FVa. Thrombosis and Haemostasis, 72, 947-956.